glp 2 vs glp 1 GLP-1 Medications for Weight Loss: Semaglutide Tirzepatide vs Retat – Revolution Health & Wellness Current Insights, Advantages and Challenges
Description
Mathur, B
Pharma companies like Roche, Amgen, Pfizer, and AstraZeneca are among the contenders expected to release additional obesity drugs in the next three to four years
September 4, 2025: Nearly 500 New Lawsuits Filed Due to Trulicity and GLP-1 Injuries Eli Lillys popular type 2 diabetes drug Trulicity is known to cause serious side effects, such as gastrointestinal conditions, blood clots, vision loss, and others
Expect more companies to start talking about positive, additive nutrition and the need to pack as many nutrients as possible into products this year
19 In the study, the researchers used a large electronic health record database to conduct a nationwide retrospective cohort study to assess the association of semaglutide with the incidence and recurrence of suicidal ideation compared with non-GLP1R agonist anti-obesity medications in individuals with overweight or obesity
